Saudi Arabia In-vitro Diagnostics Market | Growth, Trends, and Forecasts (2020

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

3.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The main factors that are propelling the growth of this market are increasing the use of point-of-care diagnostics across healthcare facilities, and rising incidence of chronic diseases in the country.

Point-of-Care (POC) technologies refer to those diagnostic tests that are conducted near the site of patient care. The result of care is timely and allows for the rapid recovery of the patient. These technologies have a major impact on diagnostic testing in Saudi Arabia. These hold the potential to significantly impact healthcare delivery and address the challenges of health disparities. Diabetes accounts for a major share of Saudi Arabia’s healthcare expenditure. POC tests make glucose testing easier and more accurate. Despite being the well-known and most-used POC diagnostics, glucometers are just one of the many POC diagnostics that are currently available commercially. Other commonly-used POC diagnostics include pregnancy testing kits, blood cholesterol testing kits, and urine analysis test strips.

Due to the ease of use and ability to provide instant results, combined with the ease of procurement, the use of POC diagnostics in Saudi Arabia is increasing rapidly. This, in turn, is promoting the growth of the IVD market in the country.

Scope of the Report

As per the scope of this report, in-vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as diabetes originated complications and cancer.

By Test Type
		Clinical Chemistry
		Molecular Diagnostics
		Immuno Diagnostics
		Haematology
		Other Types

By Product
		Instrument
		Reagent
		Other Product

By Usability
		Disposable IVD Device
		Reusable IVD Device

By Application
		Infectious Disease
		Diabetes
		Cancer/Oncology
		Cardiology
		Autoimmune Disease
		Nephrology
		Other Applications

By End-User
		Diagnostic Laboratories
		Hospitals and Clinics
		Other End-users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Immunochemistry Expected to Show Good Growth Over the Forecast Period

Immunochemistry devices deal with the study of antigen-antibody structures, biosynthesis of antibodies, antigen-antibody reactions, immunoassays, structure and properties of immune hormones, and preparation and use of monoclonal antibodies.

The factors like the rise in biomarker development in Saudi Arabia, increasing focus on drug monitoring, and increasing incidences of chronic diseases such as cancer are driving the growth of the market. The growing demand for biomarkers is propelling the growth of the immunochemistry instrument market. With the recent technological advancements in the assay systems as well as the increasing applications of biomarkers, the accuracy and yield of immunochemistry-based diagnostic tests have improved.

Some of the major market players in immunochemistry in-vitro diagnostic devices are Roche, Abbott, Danaher, and Thermo Fisher, among others.

To understand key trends, Download Sample Report

Competitive Landscape

The market for in-vitro diagnostics in Saudi Arabia is moderately competitive and major global players are actively present in the country. This is allowing high product availability in Saudi Arabia. In terms of local players for in vitro diagnostics, Saudi Arabia is behind the other neighboring countries such as South Africa. Therefore, most of the market share is grabbed by global players.

Major Players

You can also purchase parts of this report. Do you want to check out a section wise price list?

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Use of Point-of-Care (POC) Diagnostics
  2. 4.2.2 Rising Incidence of Chronic Diseases
3. 4.3 Market Restraints
  1. 4.3.1 Reimbursement Policies
4. 4.4 Porter's Five Force Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Test Type
  1. 5.1.1 Clinical Chemistry
  2. 5.1.2 Molecular Diagnostics
  3. 5.1.3 Immuno Diagnostics
  4. 5.1.4 Haematology
  5. 5.1.5 Other Types
2. 5.2 By Product
  1. 5.2.1 Instrument
  2. 5.2.2 Reagent
  3. 5.2.3 Other Product
3. 5.3 By Usability
  1. 5.3.1 Disposable IVD Device
  2. 5.3.2 Reusable IVD Device
4. 5.4 By Application
  1. 5.4.1 Infectious Disease
  2. 5.4.2 Diabetes
  3. 5.4.3 Cancer/Oncology
  4. 5.4.4 Cardiology
  5. 5.4.5 Autoimmune Disease
  6. 5.4.6 Nephrology
  7. 5.4.7 Other Applications
5. 5.5 By End-User
  1. 5.5.1 Diagnostic Laboratories
  2. 5.5.2 Hospitals and Clinics
  3. 5.5.3 Other End-users
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Abbott Laboratories
  2. 6.1.2 Becton, Dickinson and Company
  3. 6.1.3 Danaher Corporation
  4. 6.1.4 Diasorin
  5. 6.1.5 F. Hoffmann-La Roche Ltd
  6. 6.1.6 Nihon Kohden Corporation
  7. 6.1.7 Siemens Healthineers
  8. 6.1.8 Thermo Fischer Scientific

*List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments